InMed Pharmaceuticals (INM) Gross Margin (2021 - 2025)
InMed Pharmaceuticals (INM) reported Gross Margin of 22.46% for fiscal Q2 2026 (quarter ended Dec 31, 2025), down 19.00 percentage points from 41.46% a year earlier and down 13.53 percentage points from the prior quarter.
InMed Pharmaceuticals (INM) Gross Margin (2021 - 2025) Analysis & Trends
Over the twelve months ended Dec 31, 2025, InMed Pharmaceuticals' Gross Margin came in at 29.73%, down 5.66 percentage points year-over-year; for FY2025 (ended Jun 30, 2025), it was 34.53%, up 10.58 percentage points from FY2024.
- Gross Margin has a three-year change of -15.36 percentage points (FY2022 to FY2025).
- By fiscal year, Gross Margin came in at 23.94% in FY2024 (-9.98 pp), 33.93% in FY2023 (-15.97 pp) and 49.89% in FY2022.
- Five-year quarterly Gross Margin spans a low of -153.07% in fiscal Q1 2023 and a high of 67.95% in fiscal Q4 2023.
- Year over year, Gross Margin gained in four of the last eight quarters, with an average year-over-year change of +0.19 percentage points.
- The high point for year-over-year Gross Margin in five years was fiscal Q1 2024 (a gain of 155.42 percentage points); the low point was fiscal Q3 2023 (a drop of 40.26 percentage points).
- Per Business Quant data, the three fiscal quarters before Q2 2026 came in at 35.99% (Q1 2026), 44.20% (Q4 2025) and 13.92% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Linde | 217.60 Bn | 200.72 Bn | 4.43 Bn | 47.67% |
| 2 | Corning | 130.50 Bn | 123.63 Bn | 1.63 Bn | 36.14% |
| 3 | Sherwin Williams | 80.80 Bn | 79.84 Bn | 3.34 Bn | 49.17% |
| 4 | Air Products & Chemicals | 62.07 Bn | 59.97 Bn | 1.04 Bn | 32.77% |
| 5 | Corteva | 51.85 Bn | 40.65 Bn | 3.66 Bn | 57.39% |
| 6 | LyondellBasell Industries | 37.65 Bn | 27.27 Bn | 2.04 Bn | 22.21% |
| 7 | Nutrien | 34.70 Bn | 31.57 Bn | 3.25 Bn | 30.07% |
| 8 | Qnity Electronics | 26.13 Bn | 23.56 Bn | 666.00 Mn | 46.61% |
| 9 | Ati | 24.61 Bn | 22.75 Bn | 309.80 Mn | 24.57% |
| 10 | InMed Pharmaceuticals | 5.66 Mn | 3.46 Mn | - | - |
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 22.46% |
| Sep 30, 2025 | 35.99% |
| Jun 30, 2025 | 44.20% |
| Mar 31, 2025 | 13.92% |
| Dec 31, 2024 | 41.46% |
| Sep 30, 2024 | 39.02% |
| Jun 30, 2024 | 36.32% |
| Mar 31, 2024 | 24.69% |
| Dec 31, 2023 | 26.14% |
| Sep 30, 2023 | 2.36% |
| Jun 30, 2023 | 67.95% |
| Mar 31, 2023 | 18.62% |
| Dec 31, 2022 | 27.92% |
| Sep 30, 2022 | -153.07% |
| Jun 30, 2022 | 48.51% |
| Mar 31, 2022 | 58.88% |
| Dec 31, 2021 | 42.08% |
InMed Pharmaceuticals Gross Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-margin&ticker=INM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-margin", "ticker": "INM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-margin&ticker=INM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();